Documented mechanisms of action Preclinical studies (mostly Russian, to be reproduced in international protocols) report several mechanistic targets: BDNF increase (Brain-Derived Neurotrophic Factor) in the hippocampus and frontal cortex, measured by ELISA and Western blot 24-72 h post-administration Monoaminergic system modulation : cortical dopamine increase, serotonergic modulation Activation of the melanocortin pathway via MC4R receptors (residue shared with ACTH) Anti-oxidant and anti-apoptotic effect in cerebral ischaemia models (MCAO, middle cerebral artery occlusion) Experimental paradigms The most reported rodent models are the Morris water maze (spatial memory), novel object recognition (recognition memory), passive avoidance (aversive learning)
Taking GLP-1 Drugs May Put You at Risk of Rare Pirate Disease As GLP-1 weight-loss drugs soar in popularity, the list of unfortunate side effects that accompany them grows longer
[1] [4] Safety Considerations After Gallbladder Removal When considering Wegovy for patients who have undergone cholecystectomy, clinicians must evaluate the reason for gallbladder removal and ensure adequate post-operative recovery
In some people, the gut doesn't make enough natural GLP-1, or the brain isn't sensitive to it
Dai, X., Lv, X., Thompson, E
This binding stimulates the release of growth hormone (GH) in a pulsatile manner, meaning that GH is released in bursts rather than continuously